Time to End Embryo-Destroying Stem Cell Research

Eugene C. Tarne | November 17, 2015

Will induced pluripotent stem cells (iPSCs) finally replace human embryonic stem cells (hESCs) in the field of regenerative medical research?

Results of a recent study published in Nature Biotechnology argue that they should.

First, some background.

In 2007, Japanese scientist Shinya Yamanaka discovered a method to create fully pluripotent, embryonic-like stem cells from ordinary somatic (body) cells. The ability to do this had been characterized as the “holy grail” of stem cell research and, indeed, Yamanaka’s achievement changed the field of regenerative medicine. So groundbreaking was his discovery that he was awarded the Nobel Prize just five years after announcing it.

Stem Cell Awareness Day: Major Research Center’s Quest for Cures Uses Ethical Sources Only

Eugene C. Tarne | November 5, 2015

Recently, numerous research facilities, both public and private, marked “Stem Cell Awareness Day,” holding lectures, issuing statements and highlighting ongoing progress in the field of regenerative medicine.

Among those participating was the University of California, Davis, one of the country’s leading institutions for stem cell research and regenerative medicine. Writing in her local newspaper, the Davis Enterprise, Jan Nolta, the director of the Stem Cell Program at the UC Davis School of Medicine, highlighted the program’s “numerous novel clinical trials ongoing and in the pipeline” and its 16 disease teams testing stem cells to treat the following…

The Continuing Promise of Non-Embryonic Stem Cells

Eugene C. Tarne | December 8, 2014

The California based City of Hope, one of the country’s leading cancer research hospitals, recently sent out birthday greetings to the California Institute for Regenerative Medicine (CIRM), the nation’s leading funder — apart from the federal government – of stem cell research.

“On its 10th birthday, the California Institute for Regenerative Medicine celebrated 10 stem cell therapies that have been approved for clinical trials, including an HIV/AIDS trial at City of Hope,” the message read.

The birthday greeting contained an unintended irony, for while CIRM was approved by California voters a decade ago to give priority funding to human embryonic stem cell research, eight of the 10 approved clinical trials referenced by City of Hope were for research projects using adult and other non-embryonic stem cells.

Scientific Advances in Stem Cell Research Continue to Make Use of Embryos Outdated and Unnecessary

Eugene C. Tarne | November 17, 2014

Diabetes has long been one of the main diseases for which human embryonic stem cell (embryo-destroying) research, or hESCR, was claimed to hold the greatest promise of curing.

But for well over a decade now, ethically contentious human embryonic stem cell research (hESCR) has notably failed to live up to all its hype, with promises of miracle cures within “five to 10 years” remaining unfulfilled.

That remains true today, despite all the renewed hype that accompanied recent reports that researchers had coaxed hESCs into becoming insulin-producing cells.